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Impaired Functional Recovery After Stroke in the
Stroke-Prone Spontaneously Hypertensive Rat
J.K. McGill, BSc (Hons); L. Gallagher, HNC; H.V.O. Carswell, PhD;
E.A. Irving, PhD; A.F. Dominiczak, MD; I.M. Macrae, PhD
Background and Purpose—To identify if the stroke-prone spontaneously hypertensive rat (SHRSP) exhibits impaired
functional recovery after stroke compared with its normotensive reference strain, the Wistar Kyoto rat (WKY).
Methods—In study 1, a 2-mm distal middle cerebral artery occlusion (middle cerebral artery occlusion) was performed in
both strains and recovery assessed using a 33-point neurological score. Because SHRSPs displayed much larger infarcts
than WKYs, study 2 and study 3 involved extending the length of middle cerebral artery (MCA) occlusion in the WKY
to increase the volume and distribution of infarction to comparable levels with SHRSP. Animals were assessed with the
neurological score, tapered beam walk, and cylinder tests.
Results—In study 1, infarct volume (expressed as a percent of contralateral hemisphere) was WKY 13.13% and SHRSP
19.81%. Initial neurological deficit was greater (WKY 251, SHRSP 221, out of a possible 33) and subsequent
recovery was poorer in SHRSP. In studies 2 and 3, infarct volume and distribution (study 2, WKY 21.81.3%, SHRSP
22.93%; study 3, WKY 17.22%, SHRSP 16.53%) and initial neurological deficit at 2 hours after middle cerebral
artery occlusion (study 2 WKY 231, SHRSP 222; study 3 WKY 251 and SHRSP 231; meanSEM) were
comparable between strains. However, whereas WKY recovered toward normal scores, SHRSP scored significantly
lower 2 weeks (study 2) and 4 weeks (study 3) after middle cerebral artery occlusion. Beam walk data revealed
long-term impairment in SHRSP contralateral limb use, compared with WKY, at days 3, 7, and 28 (P0.05).
Conclusions—SHRSP exhibit impaired functional recovery after stroke compared with WKY. (Stroke. 2005;36:135-141.)
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Cerebral ischemia caused by occlusion of the middlecerebral artery is reported to be the most commonly
encountered type of stroke in humans,1,2,4 affecting an esti-
mated 5.5 million people worldwide.2 This can result in a
variety of disabilities, including hemiparesis and dysphagia.5
It is now widely accepted that the brain has an inbuilt ability
to recover after such an event;6,7 recently, research has
focused on the study of long-term recovery after stroke.
To investigate potential mechanisms involved in recovery
from stroke, the use of animal models of focal cerebral
ischemia, in particular rodent models, is essential.10 A clini-
cally relevant model of human stroke is the stroke-prone
spontaneously hypertensive rat (SHRSP).3,8 This strain has
been shown to have a genetic predisposition to cerebral
ischemia and exhibits hypertension and an increased sensi-
tivity to experimentally induced stroke.3,11 The Wistar Kyoto
rat (WKY) is the normotensive strain from which the
SHRSPs were derived and therefore represents a reference
control strain. Although the SHRSPs have proved invaluable
in assessing the relationship between hypertension, genetics,
and stroke, their degree of sensorimotor impairment and
subsequent functional recovery after stroke has yet to be
investigated. Understanding recovery in this clinically rele-
vant model may improve our understanding of recovery after
human stroke, which is an increasingly important aspect of
stroke research.7
Because SHRSPs are hypertensive and display a greater
sensitivity to experimental stroke, we tested the hypothesis
that they would also exhibit a poorer outcome after middle
cerebral artery occlusion compared with their reference
strain, WKY.
Materials and Methods
Animals and Housing
All experiments were performed under license from the Home
Office, United Kingdom and were subject to the Animals (Scientific
Procedures) Act of 1986. SHRSP and WKY rats were obtained from
inbred colonies within the Division of Cardiovascular and Medical
Sciences at the University of Glasgow. Male rats aged between 3 and
6 months were individually housed in standard laboratory cages and
food and water were available ad libitum. Animals were tamed by
daily handling for up to 2 weeks before surgery and behavior testing.
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Surgical Procedures: Focal Cerebral Ischemia
Anesthesia was induced with 5% halothane and maintained at 1% to
1.5% in oxygen–nitrous oxide (30:70) throughout the procedure by
intubation of the animal. Body temperature was monitored via a
rectal probe and maintained at 37°C using a heating lamp.
Study 1 included WKY (n6) and SHRSP (n5) (14-day
survival) rats. Permanent focal cerebral ischemia was induced by
electrocoagulation of the distal portion of the middle cerebral artery
using a modification of the Tamura model, as previously described.9
In study 1, a 2-mm segment of the middle cerebral artery occlusion
was electrocoagulated just distal to the inferior cerebral vein (Figure
1a). To ensure complete occlusion, the artery was cut at this position
with microscissors.
Study 2 included 6 rats per strain (14-day survival), and study 3
included WKY (n9) and SHRSP (n11) (28-day survival) rats. A
2-mm distal middle cerebral artery occlusion was performed in
SHRSPs. The occlusion began just proximal to the inferior cerebral
vein. In WKYs, the occlusion was extended more distally, up to the
first major branch of the MCA (Figure 1b).
Behavior Assessments: Neurological Score
A neurological assessment involving a 33-point score, modified from
Hunter et al,12 was used in all 3 studies. This comprised a battery of
11 tests that include assessment of paw placement, grip strength,
ability to grip a horizontal bar, visual forepaw reaching, contralateral
reflex, contralateral rotation, righting reflex, inclined plane, general
condition, motility, and circling. Thirty-three is the maximum score
the rat can achieve, and 31 to 33 would be considered normal scores.
Scoring was performed before surgery and then after middle cerebral
artery occlusion at 2 hours, 24 hours, 48 hours, 72 hours, 7 days, and
14 days/28 days.
Neurological scores were analyzed using a repeated measures
2-way analysis of variance (ANOVA) to determine the effect of time
and strain on score. Individual time points were then assessed using
an unpaired Student t test.
Tapered Beam Walk Test
This test, developed by Schallert et al,13 is a measure of forelimb and
hind limb impairments after middle cerebral artery occlusion. Ani-
mals were trained to traverse a 130-cm-long tapered beam from a
platform at one end to the animal’s home cage at the other, and the
number of foot slips onto an under-hanging ledge was recorded.
Animals were pretrained for 5 to 7 days and tested preoperatively
and then postoperatively at days 3, 7, 14, 21, and 28 in the light phase
of the light/dark cycle.
The number of foot faults made was calculated as a percentage of
the total number of steps taken.
Beam walk test data were analyzed using a repeated-measures
ANOVA to determine the effect of time and strain on the number of
foot faults made. Data were log-transformed before analysis, and
ipsilateral and contralateral faults were analyzed separately. A
follow-up least significant difference test assessed differences in
group means at individual time points.
Cylinder Test
The cylinder test, developed by Schallert et al,14 is a measure of
forelimb asymmetry after middle cerebral artery occlusion. When
placed in the cylinder, the animal will rear and explore the cylinder
walls with its forepaws, allowing 3 categories of placements to be
recorded: independent ipsilateral limb use, independent contralateral
limb use, and both movements, when the animal uses both paws in
unison or in quick succession. Animals were tested preoperatively
and then postoperatively at days 3, 7, 14, 21, and 28, using a red
lamp in the dark during the animals’ light phase, to encourage
exploratory behavior and rearing. The different forelimb preference,
for placements made, was calculated as a percentage of the total
number of placements made.
Cylinder test data were analyzed first with a mixed models
repeated-measures ANOVA to determine effect of time, strain, and
paw. A follow-up least significant difference test was used to analyze
differences between the 2 strains for days and paws used.
Brain Processing: Perfusion–Fixation
At 2 (studies 1 and 2) and 4 (study 3) weeks after middle cerebral
artery occlusion, animals were transcardially perfused with heparin-
ized saline, followed by 4% paraformaldehyde. Brains were embed-
ded in paraffin wax and 6-m sections were cut at 8 predetermined
coronal levels throughout the middle cerebral artery territory.15
Assessment of Tissue Loss
Sections from each of the 8 coronal levels were stained with
hematoxylin and eosin and assessed for tissue loss (Figure 1c). The
area of intact tissue in the ipsilateral hemisphere and the area of the
contralateral hemisphere were measured directly from sections at
each of the 8 coronal levels using an MCID Image Analyser
(Imaging Research). The volume of each hemisphere was calculated
from the area under the curve of tissue area plotted against stereo-
taxic coronal levels. The endpoints were 12.5 mm anterior and
0.05 mm posterior to the interaural line. Swanson method was used
to calculate the percent volume of tissue loss, as previously de-
scribed.16 The area of tissue loss at each coronal level was also
determined and compared in both strains.
The significance of differences in tissue loss was assessed using an
unpaired Student t test.
Results
Study 1: Volume of Tissue Loss
A 2-mm distal middle cerebral artery occlusion resulted in
mainly cortical damage (Figure 1c), which included the
Figure 1. a, Two-mm distal middle cerebral
artery occlusion with occlusion starting
from a point just distal to the inferior cere-
bral vein (ICV) and extending 2 mm distally.
b, Extended distal middle cerebral artery
occlusion in WKY (studies 2 and 3) with
occlusion starting just proximal to the ICV
and extending distally to the first major
branch of the middle cerebral artery (MCA).
c, Representative hematoxylin and eosin-
stained section showing tissue loss 4
weeks after middle cerebral artery occlu-
sion in WKY.
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sensorimotor cortex. The percent volume of tissue loss
(Figure 2a) after a 2-mm distal middle cerebral artery
occlusion was WKY 13.13% and SHRSP 19.81%
(meanSEM). Although the difference in the percent tissue
loss was not statistically significant between the 2 strains, the
distribution of tissue loss was less in WKYs than in SHRSPs
at all 8 coronal levels examined (Figure 2b and 2c). The
greatest difference was seen in dorsal regions of the motor
cortex, which include the forelimb and hind limb regions.
SHRSPs displayed substantially more damage in these areas
than WKYs.17
Neurological Score
Mean neurological scores for both strains are presented in
Figure 2d. Both SHRSPs and WKYs display a similar pattern
of behavior: an initial deficit followed by some degree of
recovery. At 2 hours after middle cerebral artery occlusion,
SHRSPs exhibited a more severe deficit than WKYs (SHRSP
221 versus WKY 251; P0.005). Repeated-measures
ANOVA revealed a significant effect of time (P0.0001) and
strain (P0.0002) on score, with WKYs scoring significantly
higher than SHRSPs from 24 hours to 14 days after middle
cerebral artery occlusion, (P0.005). At 14 days after middle
cerebral artery occlusion, SHRSPs continued to display
deficits in paw placement, grip strength, horizontal bar, and
general condition (SHRSP 260.5, WKY 31; P0.05).
Study 2: Volume of Tissue Loss
After an extended distal middle cerebral artery occlusion,
tissue loss in WKYs increased to comparable levels with
SHRSP (P0.75): WKY 21.81.3% and SHRSP 22.93%
(meanSEM) (Figure 3a). The overall distribution of damage
in WKYs now incorporated substantially more of the medial
motor cortex, including the forelimb and hind limb areas
(Figure 3b and 3c).
Neurological Score
Mean neurological scores are presented in Figure 3d. The
initial deficit in both strains is now similar, WKY 231 and
SHRSP 222 (meanSEM; P0.35). However, repeated-
measures ANOVA revealed a significant effect of time
(P0.0001) and strain (P0.0116) on score, with WKYs
scoring higher than SHRSPs from 48 hours to 14 days after
middle cerebral artery occlusion (P0.05). At 14 days after
middle cerebral artery occlusion, SHRSPs continued to dis-
play deficits in paw placement, grip strength, horizontal bar,
and general condition (SHRSP 261, WKY 301; P0.05).
Study 3: Volume of Tissue Loss
Figure 4a presents percent tissue loss in WKYs and SHRSPs
at 28 days after middle cerebral artery occlusion. Both strains
were comparable in terms of tissue loss (WKY 17.22%,
SHRSP 16.53%; meanSEM; P0.85) and displayed a
similar distribution of damage throughout the brain (Figure
4b and 4c).
Neurological Scores
Mean neurological scores are presented in Figure 4d. The
initial deficit in both strains was similar, WKY 251 and
SHRSP 231 (meanSEM), although this small difference
reached statistical significance (P0.02). Repeated-measures
ANOVA revealed a significant effect of time (P0.0001) and
strain (P0.0001) on score, with WKYs scoring significantly
higher from 2 hours postoperatively up to 28 days after
middle cerebral artery occlusion (P0.05).
Although WKYs recovered to normal scores by day 28,
SHRSPs did not. SHRSPs showed long-term deficits in paw
placement, grip strength, horizontal bar, and general condi-
tion (SHRSP 29, WKY 32; P0.05).
Beam Walk Test
Contralateral and ipsilateral foot faults for the beam walk test
are presented in Figure 5a. At 3 days after middle cerebral
Figure 2. Study 1. Distribution and
amount of tissue loss and neurological
deficit in SHRSPs (n5) and WKYs
(n6). a, Total tissue loss. b, Area of tis-
sue loss at each coronal level. c, Distri-
bution of tissue loss in the median ani-
mal from each strain. d, Neurological
scores. WKY scored significantly higher
than SHRSP from days 1 to 14 after
middle cerebral artery occlusion
(P0.005).
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artery occlusion, SHRSPs displayed a significantly greater
number of contralateral limb foot faults than WKYs. Some
evidence of recovery was apparent by day 7 in SHRSPs, but
they continued to display a greater number of faults from
days 7 to 28 compared with WKYs. There was a significant
effect of time (P0.0001) and strain (P0.016) for the
number of foot faults made with contralateral limbs. Further
analysis revealed that this effect was significant at days 3, 7,
and 28 (P0.004, 0.017, and 0.010, respectively).
Analysis of ipsilateral limb faults revealed a significant
effect of strain (P0.017). This effect was significant at days
7 and 14 (P0.03 and 0.02, respectively), with WKYs
making more ipsilateral foot faults at these time points. The
greatest number of faults was made with the hind limbs.
Figure 5b and 5c represent the number of contralateral
faults made with the forelimb and hind limb, respectively. No
additional statistical analysis was performed on these data,
but it was evident that SHRSPs made more faults with both
contralateral forelimb and hind limb from days 3 to 28,
compared with WKYs.
Cylinder Test
The number of paw placements made with contralateral,
ipsilateral, and both limbs are presented in Figure 6a, 6b, and
6c, respectively. Repeated-measures ANOVA on percent
placement data revealed no significant effect of time (P1.0)
and strain (P0.9993). Follow-up pair-wise comparisons
revealed no significant difference between the 2 strains on
Figure 3. Study 2. Distribution and
amount of tissue loss and neurological
deficit in SHRSPs and WKYs (n6/
strain). a, Total tissue loss. b, Area of
tissue loss at each coronal level. c, Dis-
tribution of tissue loss in the median ani-
mal from each strain. d, Neurological
scores. WKYs scored significantly higher
than SHRSPs from days 2 to 14 after
middle cerebral artery occlusion
(P0.05).
Figure 4. Study 3. Distribution and
amount of tissue loss and neurological
deficit in SHRSPs (n11) and WKYs
(n9). a, Total tissue loss. b, Area of tis-
sue loss at each coronal level. c, Distri-
bution of tissue loss in the median ani-
mal from each strain. d, Neurological
scores. WKYs scored higher than SHR-
SPs from 2 hours to 28 days after mid-
dle cerebral artery occlusion (P0.05).
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paws used at any time point. However, in both strains there
was evidence for a significant difference in the percentage use
of the paws after stroke. Repeated-measures ANOVA re-
vealed a significant effect of paw use (P0.0005), with the
percent number of both movements less than that for either
independent placement of the right or left paw at all time
points after middle cerebral artery occlusion in both strains.
Discussion
Investigating recovery after middle cerebral artery occlusion
in the SHRSPs and WKYs has revealed 2 important results.
Extending middle cerebral artery occlusion distally in WKYs
increased the amount of tissue loss and incorporated more
medial areas of the motor cortex, including the forelimb and
hind limb regions. This is particularly important when inves-
tigating functional recovery using behavior tests, such as the
cylinder and beam walk tests, because the same brain regions
must be affected in both strains to a similar degree for valid
conclusions to be drawn about functional recovery. When
WKYs and SHRSPs displayed similar volumes and distribu-
tion of ischemic damage, SHRSPs demonstrated an impaired
ability to recover compared with WKY and were still signif-
icantly impaired 28 days after middle cerebral artery occlu-
sion. This was shown with the 33-point neurological score
and tapered beam walk test. Interestingly, the cylinder test did
not reveal any significant degree of impairment in either
strain, even at 3 days after middle cerebral artery occlusion.
This might be explained, in part, by the areas of the brain
affected by the distal middle cerebral artery occlusion. A
distal middle cerebral artery occlusion results mainly in
cortical damage, with little if any damage to the striatum.
There is evidence to suggest that asymmetrical limb use in the
cylinder test is a consequence of both striatal and cortical
damage,20 and as such the cylinder test might not be sensitive
to focal cortical lesions.
Another interesting finding was that WKY rats made
significantly more ipsilateral limb foot faults, primarily
with the hind limb, compared with SHRSP rats in the beam
walk test. This surprising result might be explained, in
part, by compensatory mechanisms the rats are using. In
WKYs, there was improvement in the contralateral limbs
over time, as shown by the decrease in the number of
faults. However, although there was recovery, the con-
tralateral limbs in the WKYs may have been unable to
support the animal’s full weight, therefore resulting in the
ipsilateral limbs being improperly placed on the beam and
being classed as a foot fault. However, it is important to
note that the number of ipsilateral foot faults in WKYs was
small and never more than the number of contralateral foot
faults.
From 33-point neurological score data at 28 days after
middle cerebral artery occlusion, the SHRSPs showed
long-term deficits in paw placement, grip strength, hori-
zontal bar, and general condition (body weight, general
demeanor, coat appearance) compared with WKYs. The
SHRSPs were slower to regain preoperative weight, even
on supplemented diet (given to all animals). Some were
less active and adopted a hunched posture, even at 28 days.
Although there was a degree of recovery of contralateral
limb grip strength in SHRSPs, it was noticeably weaker
than the ipsilateral limb. Consequently, SHRSPs were
unable to grip the horizontal bar properly and pull both
hind limbs up onto it, resulting in a lower score in this test.
A long-lasting deficit in the inclined plane was seen in
both strains. However, this may be a consequence of
habituation because the animals’ motivation to turn and
Figure 5. Tapered beam walk test. a,
Contralateral and ipsilateral foot faults in
SHSRP and WKY. SHRSPs make signifi-
cantly more contralateral foot faults than
WKYs at days 3, 7, and 28 after middle
cerebral artery occlusion (*P0.05).
WKYs make significantly more ipsilateral
foot faults than SHRSPs at days 7 and
14 after middle cerebral artery occlusion
(#P0.05). b, Contralateral hind limb
faults. c, Contralateral forelimb faults.
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face the uphill position became less as time progressed,
despite being physically capable of completing this test.
Thus, the lower scores in this test could reflect motivation
rather than sensorimotor impairment.
Overall, these studies have demonstrated that when the
amount and distribution of tissue loss in SHRSP and WKY
is similar, SHRSPs clearly have an impaired ability to
recover compared with WKYs. To our knowledge, this is
the first study reporting such a finding.
In support of our results, a recent study by Maguire et
al19 has demonstrated a difference in functional outcome
between SHRSPs and the genetically related spontane-
ously hypertensive rats. Despite both strains displaying
similar volumes of damage, SHRSPs showed long-term
impairment, up to 28 days after middle cerebral artery
occlusion compared with the spontaneously hypertensive
rats, which showed improved recovery by day 18 after
middle cerebral artery occlusion. This might suggest,
similar to our studies, that there is some inherent, perhaps
genetic, basis for impaired recovery in the SHRSP. Inter-
estingly, the SHRSPs in this study also displayed higher
blood pressures compared with the spontaneously hyper-
tensive rats. It is therefore possible that this elevated blood
pressure and subsequent disturbances in cerebral autoreg-
ulation after middle cerebral artery occlusion in the SHR-
SPs may play a part in their impaired recovery. This has
been shown to be important in human stroke. Several
studies have shown that early lowering of high blood
pressure after ischemic stroke is associated with better
functional outcome.18 Current studies are underway to
investigate the effect of hypertension in the SHRSP on
functional outcome after stroke. Another plausible expla-
nation for the differences in functional recovery between
the 2 strains is that neuroplasticity in the SHRSP brain may
be compromised. Although the exact mechanisms involved
are poorly understood, there is overwhelming evidence
supporting a role for plasticity in functional recovery after
stroke in humans and rats.6,7,14 Work is currently underway
to determine if there are any differences in neuroplasticity
between SHRSPs and WKYs, which may underlie im-
paired recovery in the SHRSP.
In conclusion, the results of the present studies show
that when a similar size and distribution of ischemic infarct
are induced in the 2 strains, SHRSPs have an impaired
ability to recover motor function, compared with their
reference strain, the WKYs. This difference has been
demonstrated up to 28 days after middle cerebral artery
occlusion using a 33-point neurological score and tapered
beam walk test.
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